Using Chinese hamster cells grown, treated, and assayed in culture, we have examined the fractionation response relative to cell killing of two 30 minute exposures of actinomycin D, or a single exposure to this drug followed by a dose of x-rays. Asynchronous cells and cells synchronized by hydroxyurea treatment were used. We found that while an increase in 2-dose survival in 2 hours is observed with two actinomycin D exposures, this was very likely not due to repair of sublethal damage. It appeared, rather, that cell progression in the growth cycle to more resistant ages was probably responsible for the fractionation survival increase. Fractionation experiments in which a first dose of actinomycin D was followed at varying intervals by an x-ray dose supported this interpretation since we found that the drug damage able to interact with radiation damage persisted in time. In contrast to the situation when radiation is administered first, the DNA binding ability of actinomycin D probably accounts for the persistence of drug damage and the lack of significant sublethal damage repair during periods long enough for appreciable x-ray damage repair.
Skip Nav Destination
Close
Article navigation
1 November 1970
Research Article|
November 01 1970
Actinomycin D and Radiation Fractionation Studies in Asynchronous and Synchronized Chinese Hamster Cells
Radiat Res (1970) 44 (2): 484–497.
Citation
M. M. Elkind, E. Kano; Actinomycin D and Radiation Fractionation Studies in Asynchronous and Synchronized Chinese Hamster Cells. Radiat Res 1 November 1970; 44 (2): 484–497. doi: https://doi.org/10.2307/3573209
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner